These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11867174)

  • 1. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Ekbom A; Olsson R; Kornfeldt D; Lööf L; Danielsson A; Hultcrantz R; Lindgren S; Prytz H; Sandberg-Gertzén H; Almer S; Granath F; Broomé U
    J Hepatol; 2002 Mar; 36(3):321-7. PubMed ID: 11867174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort.
    de Valle MB; Björnsson E; Lindkvist B
    Liver Int; 2012 Mar; 32(3):441-8. PubMed ID: 22098097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
    Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
    J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland.
    Barner-Rasmussen N; Pukkala E; Jussila A; Färkkilä M
    Scand J Gastroenterol; 2020 Jan; 55(1):74-81. PubMed ID: 31902255
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study.
    Fevery J; Henckaerts L; Van Oirbeek R; Vermeire S; Rutgeerts P; Nevens F; Van Steenbergen W
    Liver Int; 2012 Feb; 32(2):214-22. PubMed ID: 21745316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
    Nasser-Ghodsi N; Mara K; Watt KD
    Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
    Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
    Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
    Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.
    Brandsaeter B; Friman S; Broomé U; Isoniemi H; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Bjøro K
    Scand J Gastroenterol; 2003 Nov; 38(11):1176-83. PubMed ID: 14686722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study.
    Leidenius M; Höckersted K; Broomé U; Ericzon BG; Friman S; Olausson M; Schrumpf E
    J Hepatol; 2001 Jun; 34(6):792-8. PubMed ID: 11451160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.
    Kornfeld D; Ekbom A; Ihre T
    Scand J Gastroenterol; 1997 Oct; 32(10):1042-5. PubMed ID: 9361178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis.
    Ali AH; Tabibian JH; Nasser-Ghodsi N; Lennon RJ; DeLeon T; Borad MJ; Hilscher M; Silveira MG; Carey EJ; Lindor KD
    Hepatology; 2018 Jun; 67(6):2338-2351. PubMed ID: 29244227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.